Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 42
Filtrar
Más filtros

Intervalo de año de publicación
1.
Cerebrovasc Dis ; 37(5): 364-7, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24970287

RESUMEN

BACKGROUND: The prevalence of 25-hydroxyvitamin D [25(OH)D] deficiency is high in patients presenting with an acute stroke, and it may be associated with greater clinical severity and a poor early functional prognosis. However, no data about its impact on long-term prognosis is available. In this study, we aimed to assess the association between 25(OH)D levels and 1-year mortality in stroke patients. METHODS: From February to December 2010, 382 Caucasian stroke patients admitted to the Department of Neurology of the University Hospital of Dijon, France, were enrolled prospectively. Demographics and clinical information including stroke severity assessed using the National Institutes of Health Stroke Scale score were collected. The serum concentration of 25(OH)D was measured at baseline. Multivariable Cox regression models were used to evaluate the association between 1-year all-cause mortality and serum 25(OH)D levels treated as either a log-transformed continuous variable or dichotomized (<25.7 and ≥25.7 nmol/l) at the first tertile of their distribution. RESULTS: Of the 382 stroke patients included, 63 (16.5%) had died at 1 year. The mean 25(OH)D level was lower in these patients (32.3 ± 22.0 vs. 44.6 ± 28.7 nmol/l, p < 0.001), and survival at 1 year was worse in patients in the lowest tertile of 25(OH)D levels (defined as <25.7 nmol/l); log-transformed 25(OH)D levels were inversely associated with 1-year mortality (hazard ratio, HR = 0.62; 95% confidence interval, 95% CI: 0.44-0.87; p = 0.007), and patients with 25(OH)D levels <25.7 nmol/l were at a higher risk of death at 1 year (HR = 1.95; 95% CI: 1.14-3.32; p = 0.014). In multivariable analyses, the association was no longer significant but a significant interaction was found for age, and stratified analyses by age groups showed an inverse relationship between 25(OH)D levels and 1-year mortality in patients aged <75 years [HR = 0.38; 95% CI: 0.17-0.83; p = 0.015 for log-transformed 25(OH)D levels, and HR = 3.12; 95% CI: 0.98-9.93; p = 0.054 for 25(OH)D levels <25.7 vs. >25.7 nmol/l]. CONCLUSION: A low serum 25(OH)D level at stroke onset may be associated with higher mortality at 1 year in patients <75 years old. Further studies are needed to confirm these findings and to determine whether vitamin D supplementation could improve survival in stroke patients.


Asunto(s)
Accidente Cerebrovascular/mortalidad , Vitamina D/análogos & derivados , Vitamina D/sangre , Factores de Edad , Anciano , Anciano de 80 o más Años , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Pronóstico , Modelos de Riesgos Proporcionales , Factores de Riesgo , Accidente Cerebrovascular/sangre
2.
Clin Chem Lab Med ; 52(4): 511-20, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24152903

RESUMEN

BACKGROUND: Several recent studies have shown some discrepancies between 25-hydroxyvitamin D [25(OH)D] assay methods, despite some improvement in the past few years. The accuracy of 25(OH)D assay methods is still a real challenge for clinical laboratories. The aim of this study was to assess the agreement between a large panel of routine assays and a two-dimensional liquid chromatography/tandem mass spectrometry (2D LC-MS/MS) method, selected as the reference method. METHODS: Forty-nine human plasma samples with only endogenous 25(OH)D3 were analyzed with 11 different methods, especially with three LC-UV methods that differed in the extraction step. Seven routine immunoassays were also tested: two manual (RIA and EIA from IDS) and five fully-automated methods. The results of the 25(OH)D3 assays were compared with those of the 2D LC-MS/MS method using weighted Deming regression analysis, Bland-Altman plots and concordance correlation coefficient (CCC). The ability of these methods to properly classify patients was evaluated by sorting results depending on vitamin D status. RESULTS: The CCC was >0.90 for the three LC-UV methods and for most of the automated IA, meaning substantial agreement with 2D LC-MS/MS results. The ability to properly classify patients according to their vitamin D status was overall satisfactory for most of the methods tested (concordance >90%). CONCLUSIONS: The immunoassays available on Liaison, Isys, Architect and Elecsys, together with our in-house LC-UV method preceded by an SLE step met the minimum requirements for the assessment of vitamin D status in clinical laboratories.


Asunto(s)
Inmunoensayo , Espectrometría de Masas en Tándem , Vitamina D/análogos & derivados , Cromatografía Líquida de Alta Presión , Humanos , Reproducibilidad de los Resultados , Vitamina D/sangre , Vitamina D/inmunología
3.
BMC Infect Dis ; 13: 7, 2013 Jan 07.
Artículo en Inglés | MEDLINE | ID: mdl-23295013

RESUMEN

BACKGROUND: Even though it has been suggested that antiretroviral therapy has an impact on severe hypovitaminosis D (SHD) in HIV infected patients, it could be speculated that the different levels of residual inflammation on HAART (Highly Active Anti Retroviral Therapy) could contribute to SHD and aggravate bone catabolism in these patients. METHODS: A cross-sectional study was carried out in an unselected cohort of 263 HIV infected outpatients consulting during Spring 2010. Clinical examinations were performed and medical history, food habits, sun exposure and addictions were collected. Fasting blood samples were taken for immunological, virological, inflammation, endocrine and bone markers evaluations. RESULTS: Ninety-five (36%) patients had SHD. In univariate analysis, a significant and positive association was found between SHD and IL6 (p = 0.001), hsCRP (p = 0.04), increased serum C-Telopeptides X (CTX) (p = 0.005) and Parathyroid Hormon (PTH) (p < 0.0001) levels. In multivariate analysis, SHD deficiency correlated significantly with increased IL-6, high serum CTX levels, lower mean daily exposure to the sun, current or past smoking, hepatitis C, and functional status (falls), but not with the time spent on the current HAART (by specific drug or overall). CONCLUSIONS: SHD is frequent and correlates with inflammation in HIV infected patients. Since SHD is also associated with falls and increased bone catabolism, it may be of interest to take into account not only the type of antiretroviral therapy but also the residual inflammation on HAART in order to assess functional and bone risks. This finding also suggests that vitamin D supplementation may be beneficial in these HIV-infected patients.


Asunto(s)
Infecciones por VIH/complicaciones , Infecciones por VIH/metabolismo , Mediadores de Inflamación/metabolismo , Deficiencia de Vitamina D/etiología , Deficiencia de Vitamina D/metabolismo , Adulto , Anciano , Terapia Antirretroviral Altamente Activa , Biomarcadores/metabolismo , Huesos/metabolismo , Femenino , Infecciones por VIH/tratamiento farmacológico , Humanos , Masculino , Persona de Mediana Edad , Factores de Riesgo , Adulto Joven
4.
Rev Prat ; 63(8): 1060-9, 2013 Oct.
Artículo en Francés | MEDLINE | ID: mdl-24298822

RESUMEN

In industrialized countries, the major vitamin deficiency syndromes have virtually disappeared. Today they are superseded by marginal deficits, characterized by insufficient vitamins reserves to maintain normal physiologic state. These states strike populations such as infants, pregnant women, alcoholics and the elderly, and may have long-term adverse effects on health. This assumption stems from the analysis of studies that show an increase in the incidence of various diseases such as cancers and cardiovascular, ocular and osteoarticular pathologies in subjects with low vitamin status. Although causal relationships are difficult to establish, a huge scope for public health appears to be open for vitamins, substituting the notion of minimal intake, indispensable to prevent signs of deficiency, to that ensuring optimal health in the medium and long-terms. However, the paradoxical character of the results obtained in several randomized trials should prompt caution in the use of vitamin supplements to prevent chronic diseases.


Asunto(s)
Vitaminas/administración & dosificación , Vitaminas/fisiología , Anciano , Anciano de 80 o más Años , Avitaminosis/diagnóstico , Avitaminosis/terapia , Suplementos Dietéticos/efectos adversos , Femenino , Humanos , Recién Nacido , Embarazo , Práctica Profesional
5.
Rev Prat ; 63(8): 1074-5, 1077-8, 2013 Oct.
Artículo en Francés | MEDLINE | ID: mdl-24298824

RESUMEN

Vitamin B1 (or thiamine) plays a key role in energy production from glucose. Since the main fuel of the nervous system is glucose, thiamine deficiency causes severe neurological symptoms. The biological exploration of vitamin B1 status is based on the measurement of thiamine pyrophosphate concentration or of the activity of a thiamine-dependent enzyme, transketolase, in erythrocytes. Severe deficiency states can be observed in chronic alcoholics, after protracted vomiting during pregnancy and after bariatric surgery. Mild deficiencies are common in the general population, but their clinical consequences are still unclear.


Asunto(s)
Deficiencia de Tiamina , Tiamina/fisiología , Adulto , Niño , Femenino , Humanos , Embarazo , Deficiencia de Tiamina/complicaciones , Deficiencia de Tiamina/diagnóstico , Deficiencia de Tiamina/etiología , Deficiencia de Tiamina/terapia
6.
Rev Prat ; 63(8): 1097-8, 1101-4, 2013 Oct.
Artículo en Francés | MEDLINE | ID: mdl-24298828

RESUMEN

There is a recent renewed interest in vitamin D, due to its description as a hormone with a positive impact on global health. Even though many former epidemiological studies have suggested a possible link between a low vitamin D status and the risk of developing chronic diseases, recent data have proven to be more discordant or modest. Looking forward to clearly needed randomized intervention studies, optimal vitamin D status and intakes should be defined on the basis of the vitamin D indisputable effects on calcium homeostasis and skeletal mineralization.


Asunto(s)
Deficiencia de Vitamina D , Vitamina D/fisiología , Humanos , Ingesta Diaria Recomendada , Estándares de Referencia , Vitamina D/administración & dosificación , Vitamina D/sangre , Deficiencia de Vitamina D/diagnóstico , Deficiencia de Vitamina D/epidemiología , Deficiencia de Vitamina D/etiología , Deficiencia de Vitamina D/terapia
7.
Rev Prat ; 63(8): 1079, 1081-4, 2013 Oct.
Artículo en Francés | MEDLINE | ID: mdl-24298825

RESUMEN

Vitamin B9 is represented by the group of folate, whose structure is derived from folic acid. The biologically active form is reduced tetrahydrofolates, serving as an essential cofactor in methylation reactions, including the vitamin B12-dependent formation of methionine from homocysteine, and as a carrier of one-carbon units involved in the synthesis of purines and pyrimidines. Folate deficiency is associated with hyperhomocysteinemia, megaloblastic anemia, leuco- and thrombocytopenia, cardiovascular disease, embryonic defects, in particular neural tube defects, and, possibly, malignancies, depression and cognitive impairment.


Asunto(s)
Deficiencia de Ácido Fólico , Ácido Fólico/fisiología , Femenino , Deficiencia de Ácido Fólico/diagnóstico , Deficiencia de Ácido Fólico/etiología , Deficiencia de Ácido Fólico/terapia , Humanos , Embarazo , Factores de Riesgo
8.
Rev Prat ; 63(8): 1085-7, 1089-90, 2013 Oct.
Artículo en Francés | MEDLINE | ID: mdl-24298826

RESUMEN

The term "vitamin B12" refers to four cobalamins (Cbl), including methyl-Cbl and adenosyl-Cbl, the two enzyme co-factors of methionine synthase and methylmalonyl-CoA mutase, respectively. Vitamin B12 deficiency produces clinical disorders that include mainly megaloblastic anaemia, peripheral and central neurological manifestations. The clinical significance of low blood B12 concentrations in the absence of manifestations of deficiency is a matter of debate. The biochemical diagnosis of the subclinical and clinical deficiency of vitamin B12 has been enriched by several parameters, including serum methylmalonic acid, homocysteine, and holo-transcobalamine, which have been evaluated over the past two decades.


Asunto(s)
Deficiencia de Vitamina B 12 , Vitamina B 12/fisiología , Humanos , Trastornos Nutricionales/diagnóstico , Trastornos Nutricionales/etiología , Trastornos Nutricionales/terapia , Vitamina B 12/sangre , Deficiencia de Vitamina B 12/diagnóstico , Deficiencia de Vitamina B 12/etiología , Deficiencia de Vitamina B 12/terapia
9.
J Pharmacol Exp Ther ; 339(3): 807-14, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21934029

RESUMEN

The molecular mechanisms underlying doxorubicin (DOX)-induced cardiomyopathy include alterations in cardiomyocytes' oxidative stress status and in gene expression. Although such alterations have been reported during in vivo DOX treatment of animals, it remains to be clarified whether they persist after treatment cessation. To address this question, rats were injected with either saline (1 ml/kg/day i.p; control) or DOX (1 mg/kg/day i.p.) for 10 days, and 70 days later cardiac functional parameters were evaluated in vivo by left ventricular catheterization. Hearts were also harvested for histological analyses as well as measurements of oxidative stress parameters by various techniques and gene expression by quantitative polymerase chain reaction of markers of cardiac pathological remodeling, namely atrial natriuretic factor, myosin heavy chain ß, vascular endothelial growth factor A (VEGF-A), and sarcoplasmic reticulum Ca(+2) ATPase. Compared with controls, DOX-treated rats displayed marked alterations in most parameters even 2 months after cessation of treatment. These included 1) lower left ventricular contractility (+dP/dt), 2) increased levels of plasma and myocardial oxidative stress markers, namely thiobarbituric acid reactive substances or dihydroethidium fluorescence, and 3) markedly altered transcript levels for all measured markers of cardiac remodeling, except VEGF-A. These changes correlated significantly with +dP/dt values assessed in the two groups of animals. In conclusion, this study demonstrated that as many as 2 months after cessation of DOX treatment cardiac alterations persisted, reflecting increased oxidative stress and pathological remodeling, the latter being linked to the development of contractile dysfunction.


Asunto(s)
Antibióticos Antineoplásicos/toxicidad , Cardiotoxinas/toxicidad , Doxorrubicina/toxicidad , Cardiopatías/genética , Miocardio/patología , Estrés Oxidativo/efectos de los fármacos , Remodelación Ventricular/genética , Animales , Antibióticos Antineoplásicos/farmacología , Peso Corporal/efectos de los fármacos , Cardiotoxinas/farmacología , Colágeno/análisis , Doxorrubicina/farmacología , Evaluación Preclínica de Medicamentos , Radicales Libres/sangre , Cardiopatías/inducido químicamente , Cardiopatías/patología , Masculino , ARN Mensajero/análisis , ARN Mensajero/genética , Ratas , Ratas Wistar , Superóxidos/análisis , Sustancias Reactivas al Ácido Tiobarbitúrico/análisis , Factores de Tiempo , Remodelación Ventricular/efectos de los fármacos
10.
Arterioscler Thromb Vasc Biol ; 28(5): 954-60, 2008 May.
Artículo en Inglés | MEDLINE | ID: mdl-18276906

RESUMEN

OBJECTIVE: Asymmetrical dimethylarginine (ADMA) is an endogenous competitive inhibitor of nitric oxide (NO) synthases. From a prospective cohort of patients with acute myocardial infarction (MI), we aimed to analyze the predictive value of circulating ADMA concentrations on prognosis. METHODS AND RESULTS: Blood samples from 249 consecutive patients hospitalized for acute MI <24 hours were taken on admission. Serum levels of ADMA and its stereoisomer, symmetrical dimethylarginine (SDMA), were determined using high-performance liquid chromatography. The independent predictors of ADMA were glomerular filtration rate, female sex, and SDMA (R(2)=0. 25). Baseline ADMA levels were higher in patients who had died than in patients who were alive at 1 year follow-up (1.23 [0.98 to 1.56] versus 0.95 [0.77 to 1.20] micromol/L, P<0.001). By Cox multivariate analysis, the higher tertile of ADMA (median [interquartile range]: 1.45 [1.24 to 1.70] micromol/L) was a predictor for mortality (Hazard Ratio [95% CI], 4.83 [1.59 to 14.71]), when compared to lower tertiles, even when adjusted for potential confounders, such as acute therapy, biological, and clinical factors. CONCLUSIONS: Our study suggests that the baseline ADMA level has a strong prognostic value for mortality after MI, beyond traditional risk factors and biomarkers.


Asunto(s)
Arginina/análogos & derivados , Infarto del Miocardio/sangre , Infarto del Miocardio/mortalidad , Anciano , Anciano de 80 o más Años , Arginina/sangre , Biomarcadores/sangre , Estudios de Cohortes , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Pronóstico , Estudios Prospectivos , Análisis de Regresión
11.
Free Radic Res ; 42(3): 226-36, 2008 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-18344117

RESUMEN

Among their pleiotropic effects, statins exert antioxidant and anti-inflammatory properties. The aim of this study was to evaluate in normotensive (WKY) and in spontaneously hypertensive rats (SHR) the effect of rosuvastatin (ROSU) treatment on (1) plasma inflammation markers and endogenous NO synthase inhibitor (ADMA) levels, (2) reactive oxygen species (ROS) generated by circulating leukocytes and (3) vascular oxidative stress and tissue inflammation markers. Plasma cytokines were higher in SHR than in WKY, except for IL-4, which was lower in SHR than in WKY. SHR monocytes exhibited higher production of ROS than did WKY monocytes. In the experimental conditions, ROSU did not modify plasma cholesterol levels in SHR but attenuated the increase in systolic blood pressure. In SHR only, ROSU lessened pro-inflammatory cytokines and ADMA levels, increased IL-4 and reduced ROS production in circulating monocytes. These results demonstrate the beneficial effects of ROSU in SHR, independently of any lowering of cholesterol levels.


Asunto(s)
Antihipertensivos/farmacología , Fluorobencenos/farmacología , Pirimidinas/farmacología , Sulfonamidas/farmacología , Animales , Arginina/análogos & derivados , Arginina/metabolismo , Presión Sanguínea , Inhibidores de Hidroximetilglutaril-CoA Reductasas/farmacología , Inflamación , Interleucina-4/metabolismo , Masculino , NADPH Oxidasas/metabolismo , Estrés Oxidativo , Ratas , Ratas Endogámicas SHR , Ratas Endogámicas WKY , Especies Reactivas de Oxígeno/metabolismo , Rosuvastatina Cálcica
14.
PLoS One ; 13(5): e0193352, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29813097

RESUMEN

AIMS: To study how MTHFR 677C→T genotype modulates the effect of supplementation with B-vitamins on total homocysteine (tHcy) and B-vitamin concentrations. METHODS: 2381 patients with a personal history of cardiovascular disease were randomly assigned to one of four groups: 1) B-vitamins alone (560 µg of 5-methyl-THF, 3 mg of vitamin B6 and 20 µg of vitamin B12), 2) n-3 fatty acids alone (600 mg of EPA and DHA in a 2:1 ratio), 3) B-vitamins and n-3 fatty acids, and 4) placebo. Participants were followed up for 4.7 years. At baseline and annually thereafter, biological parameters were assessed. Multivariate and linear mixed models were fit to study the interaction between B-vitamins and MTHFR genotype. RESULTS: Among supplemented participants, concentrations of all three B-vitamins increased during the first year (all p<0.0001) across MTHFR genotype categories. tHcy decreased by 26.3% during the first year (p<0.0001), then steadily increased throughout the 5 years (ptrend<0.001). However, at the end of follow-up, that increase was smaller among TT than among CT or CC subjects (pinteraction<0.02). At baseline, the difference in tHcy concentrations between TT homozygous and CC homozygous subjects was 2.33 µmol/l (p<0.001). After 5 years, that difference was reduced to 1.06 µmol/l and remained statistically significant (p<0.001). CONCLUSION: Participants with the TT genotype exhibited a lower 5-year decrease in tHcy concentrations following a B-vitamin supplementation than did participants with the CC or CT genotype. CLINICAL TRIAL REGISTRATION: Current Controlled Trials # ISRCTN41926726.


Asunto(s)
Enfermedades Cardiovasculares/tratamiento farmacológico , Suplementos Dietéticos , Homocisteína/sangre , Metilenotetrahidrofolato Reductasa (NADPH2)/genética , Polimorfismo Genético , Complejo Vitamínico B/administración & dosificación , Enfermedades Cardiovasculares/genética , Enfermedades Cardiovasculares/fisiopatología , Método Doble Ciego , Femenino , Genotipo , Humanos , Masculino , Persona de Mediana Edad
15.
Clin Biochem ; 40(1-2): 66-72, 2007 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-17020756

RESUMEN

OBJECTIVES: We sought to investigate the association between increased levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, and total plasma homocysteinemia (tHcy) in patients with acute myocardial infarction (AMI). DESIGN AND METHODS: In 138 patients hospitalized for AMI <24 h on admission, serum levels of ADMA, its symmetric stereoisomer (SDMA) and tHcy were measured. RESULTS: ADMA was positively associated with SDMA (p<0.001) and tHcy (p=0.03) but not with estimated glomerular filtration rates (eGFR, p=0.96), while tHcy strongly correlated with eGFR (p=0.002) and SDMA (p<0.001). By multiple linear regression, SDMA but not ADMA was independently associated with tHcy (p=0.005). CONCLUSION: Our findings suggest that, in AMI patients, hyperhomocysteinemia is indirectly related to ADMA levels via renal function. Moreover, ADMA level was independent of traditional cardiovascular risk factors in AMI patients. Interestingly, our findings suggest that SDMA could be a good risk indicator for cardiovascular disease in AMI patients.


Asunto(s)
Arginina/análogos & derivados , Hiperhomocisteinemia/complicaciones , Infarto del Miocardio/complicaciones , Anciano , Arginina/sangre , Arginina/química , Femenino , Homocisteína/sangre , Humanos , Masculino , Persona de Mediana Edad , Análisis de Regresión , Factores de Riesgo , Estadísticas no Paramétricas , Estereoisomerismo
16.
PLoS One ; 12(1): e0169979, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28125604

RESUMEN

OBJECTIVES: We aimed to investigate whether SDMA- symmetric dimethylarginine -the symmetrical stereoisomer of ADMA- might be a marker of left ventricular function in AMI. BACKGROUND: Asymmetric dimethylarginine (ADMA) has been implicated in the prognosis after acute myocardial infarction (AMI) and heart failure (HF). METHODS: Cross sectional prospective study from 487 consecutive patients hospitalized <24 hours after AMI. Patients with HF on admission were excluded. Serum levels of ADMA, SDMA and L-arginine were determined using HPLC. Glomerular filtration rate (eGFR) was estimated based on creatinine levels. Outcomes were in-hospital severe HF, as defined by Killip class >2, and death. RESULTS: Patients were analysed based on SDMA tertiles. Sex, diabetes, dyslipidemia, and prior MI were similar for all tertiles. In contrast, age and hypertension increased across the tertiles (p<0.001). From the first to the last tertile, GRACE risk score was elevated while LVEF and eGFR was reduced. The rate of severe HF and death were gradually increased across the SDMA tertiles (from 0.6% to 7.4%, p = 0.006 and from 0.6% to 5.0%, p = 0.034, respectively). Backward logistic multivariate analysis showed that SDMA was an independent estimate of developing severe HF, even when adjusted for confounding (OR(95%CI): 8.2(3.0-22.5), p<0.001). Further, SDMA was associated with mortality, even after adjustment for GRACE risk score (OR(95%CI): 4.56(1.34-15.52), p = 0.015). CONCLUSIONS: Our study showed for the first time that SDMA is associated with hospital outcomes, through altered LVEF and may have biological activity beyond renal function.


Asunto(s)
Arginina/análogos & derivados , Insuficiencia Cardíaca/sangre , Infarto del Miocardio/sangre , Insuficiencia Renal Crónica/sangre , Anciano , Arginina/sangre , Femenino , Tasa de Filtración Glomerular , Insuficiencia Cardíaca/fisiopatología , Hospitales , Humanos , Masculino , Persona de Mediana Edad , Infarto del Miocardio/fisiopatología , Óxido Nítrico/sangre , Pronóstico , Insuficiencia Renal Crónica/fisiopatología , Resultado del Tratamiento , Función Ventricular Izquierda/fisiología
17.
Am J Clin Nutr ; 83(3): 701-7, 2006 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-16522920

RESUMEN

BACKGROUND: Methylenetetrahydrofolate reductase (MTHFR) 677C-->T polymorphism is heterogeneously distributed worldwide, with the highest and lowest frequencies of the T allele in Mexico and Africa, respectively, and a south-to-north gradient in Europe. Distribution of MTHFR 1298A-->C is less well known. It has been hypothesized that 677T frequency could result in part from gene-nutrient interactions. OBJECTIVE: The objective was to compare the association of 677T and 1298C alleles with plasma concentrations of homocysteine, folate, and vitamin B-12 in geographical areas with contrasting 677T allele frequencies. DESIGN: Healthy young adults (n = 1277) were recruited in Mexico City, the West African countries of Bénin and Togo, France, and Sicily (Italy). Homocysteine, folate, and vitamin B-12 were measured in plasma, and MTHFR polymorphisms were measured in genomic DNA. RESULTS: Mexico City and Sicily reported the highest and Bénin and Togo reported the lowest plasma concentrations of folate. Mexico City had the highest 677T allele prevalence and the lowest influence of 677TT genotype on homocysteine, whereas the opposite was observed in Africa. The prevalence of the 1298C allele was lowest in the Mexicans and Africans and highest in the French. The percentage of the 677T genotype was significantly associated with the folate concentrations in 677CC carriers in a univariate analysis (R = 0.976; 95% CI: 0.797, 0.996; P < 0.0002) and in a multiple regression model that included homocysteine, vitamin B-12, and age (P = 0.0002). CONCLUSION: Our data agree with the hypothesis of a gene-nutrient interaction between MTHFR 677C-->T polymorphism and folate status that may confer a selective advantage of TT-homozygous genotype when dietary intake of folate is adequate, at least in the areas studied.


Asunto(s)
Ácido Fólico/sangre , Homocisteína/sangre , Metilenotetrahidrofolato Reductasa (NADPH2)/genética , Polimorfismo Genético , Vitamina B 12/sangre , Adolescente , Adulto , África Occidental , Alelos , Europa (Continente) , Femenino , Frecuencia de los Genes , Genotipo , Humanos , Masculino , México , Persona de Mediana Edad , Análisis de Regresión
18.
Vascul Pharmacol ; 45(2): 112-21, 2006 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16769252

RESUMEN

It has not been completely demonstrated if hypertension may, in part, develop as a result of increased oxidative stress (OS), inflammation and little is known about the short-term effects of antioxidant therapy. This study was designed to appreciate the effect of 7 days vitamin C-enriched diet (5 g/kg/day) on hemodynamic function and vascular OS in normotensive Wistar Kyoto rats and hypertensive rats (SHR). Aorta NAD(P)H oxidase activity was determinate and free radicals evaluated by electron spin resonance with a spin probe CP-H. Matrix metalloproteinase-1 (MMP-1) and monocyte chemoattractant protein-1 (MCP-1) expression were measured. The treatment with vitamin C did not change arterial pressure in SHR but prevented the increase in OS levels in SHR aortas. MMP-1 and MCP-1 expressions were more intense in the media of SHR aortas than in those of WKY rats but these expressions were not modified by vitamin C-pretreatment. Vitamin C-pretreatment was not able to protect heart against in vitro ischemia-reperfusion dysfunctions. These data may suggest that treatment with high doses of vitamin C in SHR can limit over-production of reactive oxygen species; however this effect was not accompanied with changes in arterial pressure and protection against I-R dysfunctions. Dissociation between vascular oxidative stress and cardiovascular function may be evoked.


Asunto(s)
Ácido Ascórbico/farmacología , Corazón/efectos de los fármacos , Hipertensión , Estrés Oxidativo/efectos de los fármacos , Animales , Antioxidantes/metabolismo , Antioxidantes/farmacología , Aorta/metabolismo , Ácido Ascórbico/sangre , Ácido Ascórbico/metabolismo , Presión Sanguínea/efectos de los fármacos , Quimiocina CCL2/metabolismo , Hipertensión/tratamiento farmacológico , Hipertensión/metabolismo , Masculino , Metaloproteinasa 1 de la Matriz/metabolismo , NADPH Oxidasas/metabolismo , Técnicas de Cultivo de Órganos , Ratas , Ratas Endogámicas SHR , Ratas Endogámicas WKY , Daño por Reperfusión/metabolismo , Factores de Tiempo
19.
J Comp Neurol ; 468(1): 135-50, 2004 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-14648696

RESUMEN

To investigate the evolutionary transition that has shaped the catecholaminergic systems of vertebrates, the organization of catecholamine-synthesizing neurons and the nature of the catecholamines were examined in the central nervous system of adult amphioxus (Branchiostoma lanceolatum), a cephalochordate. We isolated a gene transcript encoding tyrosine hydroxylase (TH), the limiting enzyme of catecholamine biosynthesis, and studied its distribution together with that of dopamine and serotonin. Dopamine and TH are found in the same neurons of which they are three separate populations. Two are located in the anterior brain, the first being dorsal and lying in a row and the second being more posterior and lateral. A third population comprising a few dorsal commissural neurons was found in the posterior brain. The anterior dopaminergic cells innervate the ventral commissure of the cephalic vesicle, the hindbrain, and the spinal cord. A serotonin-containing cell group is located in the same plane as the second dopaminergic cell population but is more caudal, marking the probable transition between anterior brain and hindbrain, as deduced from gene expression patterns. The overall distribution of dopaminergic and serotoninergic systems is similar in amphioxus and vertebrate central nervous system and could be an ancestral character of chordates. As assayed by high-performance liquid chromatography and electrochemical detection, significant amounts of dopamine and octopamine, but not of noradrenaline, are present in amphioxus head. This finding is consistent with data obtained from most prostomian species. We conclude that the noradrenergic system is probably an innovation of vertebrates that appeared along with the neural crest and specific hindbrain nuclei.


Asunto(s)
Sistema Nervioso Central/química , Cordados no Vertebrados , Dopamina/análisis , Neuronas/química , Norepinefrina/análisis , Serotonina/análisis , Tirosina 3-Monooxigenasa/análisis , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Catecolaminas/análisis , Sistema Nervioso Central/enzimología , Cromatografía Líquida de Alta Presión , Dopamina/genética , Hibridación in Situ , Datos de Secuencia Molecular , Neuronas/enzimología , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Serotonina/genética , Tirosina 3-Monooxigenasa/genética
20.
Am J Clin Nutr ; 78(2): 334-8, 2003 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12885718

RESUMEN

BACKGROUND: Previous studies on the effects of alcohol consumption on total plasma homocysteine (tHcy) concentrations showed contradictory results. The conflicting results may derive in part from confounding by the type of alcoholic beverage consumed. OBJECTIVE: The objective of the study was to evaluate in a predominantly wine-drinking French population whether the relation between alcohol consumption and homocysteine concentrations is dependent on the type of alcoholic beverage consumed. DESIGN: In 1996, a cross-sectional study measuring tHcy and red blood cell folate concentrations was conducted in 1196 middle-aged women and men from the French Supplementation with Antioxidant Vitamins and Minerals Study. Intakes of alcohol, energy, coffee, and B vitamins were assessed by 6 separate 24-h dietary records from the previous year. RESULTS: tHcy concentrations were positively associated with wine intake (P = 0.01) in the women and with beer intake in the men (P = 0.002). No association with the consumption of spirits was observed. The association between beer consumption and tHcy concentrations in the men was modified by the consumption of wine; the association was positive in wine drinkers, whereas an inverse trend was seen in those who drank no wine. CONCLUSION: Wine consumption may increase tHcy concentrations, whereas beer consumption seems to have no effect (or even an inverse effect) on tHcy.


Asunto(s)
Consumo de Bebidas Alcohólicas , Antioxidantes/administración & dosificación , Cerveza , Homocisteína/sangre , Vino , Adulto , Registros de Dieta , Método Doble Ciego , Femenino , Francia , Humanos , Masculino , Persona de Mediana Edad , Minerales/administración & dosificación , Minerales/farmacología , Factores Sexuales , Vitaminas/administración & dosificación , Vitaminas/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA